Figure 3.
Time dependent changes in quality of life (QOL) assessed by the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The total point mean ± the standard error are shown. There was a significant increase in the total score, indicating a negative impact on QOL, from baseline to 1 month after administration of low to moderate doses of anthracycline-based chemotherapy that was maintained through 6 months.